We met with David Smadja (Shaare Zedek Medical Center, Jerusalem, Israel) to talk about the challenges of nanoparticle design and the challenges in drug delivery at ESCRS 2019.
1. What are the limitations of current methods of ocular drug delivery? (0:04)
2. What challenges that have to be overcome with nanoparticles in order to improve drug delivery? (1:48)
3. What factors should be considered when optimising nanoparticle design? (3:29)
4. What other innovations would you like to highlight? (5:42)
Support: No funding was received in the production of this video.
Share this Video
Related Videos In Refractive Surgery
Gregory Parkhurst, AAO 2022: Advice for transitioning to implantable collamer lens
In this touchOPHTHALMOLOGY interview about his AAO 2022 presentation, Dr Gregory Parkhurst (Parkhurst NuVision, San Antonio, TX, US) talked to about the best practices for helping patients when they considering implantable collamer lens and provides some insightful suggestion to consulting physicians. ‘I Can’t Have LASIK … Now What? Transitioning to ICL surgery’ was presented at […]
Gregory Parkhurst, AAO 2022: I can’t have LASIK … Now what? Transitioning to implantable collamer lens
In this touchOPHTHALMOLOGY interview, Dr Gregory Parkhurst (Parkhurst NuVision, San Antonio, TX, US) discusses his AAO 2022 presentation about transitioning patients from LASIK eye surgery to implantable collamer lens. ‘I Can’t Have LASIK … Now What? Transitioning to ICL’ was presented at the annual American Academy of Ophthalmology (AAO) meeting, 30 September – 3 October […]
Manuel Vidal Sanz, European Association for Vision and Eye Research: Presidential Update 2022 Part 2
The European Association for Vision and Eye Research (EVER) is the leading ophthalmological research association in Europe, which covers all areas of ophthalmology and the visual sciences. One of the main activities of EVER is the organizing of a high-quality research meeting every year at a location chosen for its access and congress facilities. EVER […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!